SCHEMBL6083570

SCHEMBL6083570

Cc1cccc([CH]O)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8862001 0.81 PTGS1 (0.60)
Formic Acid SCHEMBL26965059 0.79 TP53 (0.54)
SCHEMBL1795130 0.79 PTGS1 (0.69)
SCHEMBL21847980 0.79 PTGS1 (0.69)
SCHEMBL3302772 0.79 TP53 (0.65)
SCHEMBL1795132 0.79 PTGS1 (0.69)
SCHEMBL1005454 0.77
SCHEMBL30268861 0.76 TP53 (0.56)
SCHEMBL27567537 0.76 TP53 (0.56)
SCHEMBL23457950 0.75 TP53 (0.60)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2900645-A1 3-PHENYLISOXAZOLIN DERIVATIVES WITH HERBICIDAL ACTION Bayer CropScience AG (DE) 2015-08-05 EP disclosed
US-7071359-B1 Neuropathy improvers containing nitrogenous compounds as the active ingredient TEIJIN LIMITED (JP) 2006-07-04 US disclosed
EP-1201235-B1 NEUROPATHY IMPROVERS CONTAINING NITROGENOUS COMPOUNDS AS THE ACTIVE INGREDIENT TEIJIN LTD (JP) 2005-10-12 EP disclosed
CN-1500086-A Aminopiperidine derivatives 霍夫曼-拉罗奇有限公司 2004-05-26 CN disclosed
EP-1417202-A2 AMINOPIPERIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY F. HOFFMANN-LA ROCHE AG (CH) 2004-05-12 EP disclosed
US-20030069276-A1 Amino piperidine derivatives F.HOFFMANN-LA ROCHE AG (CH) 2003-04-10 US disclosed
EP-0993458-B1 3-BENZYLPIPERIDINE MERCK PATENT GMBH (DE) 2003-04-09 EP disclosed
WO-2002079186-A2 AMINOPIPERIDINE DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY F. HOFFMANN-LA ROCHE AG (CH) 2002-10-10 WO disclosed
EP-1201235-A1 NEUROPATHY IMPROVERS CONTAINING NITROGENOUS COMPOUNDS AS THE ACTIVE INGREDIENT TEIJIN LIMITED (JP) 2002-05-02 EP disclosed
US-6333339-B1 CENTRAL SYSTEM DISORDERS, SCHIZOPHRENIA AND COGNITION ACTIVATORS MERCK PATENT GELLSCHAFT MIT BESCHRANKTER (DE) 2001-12-25 US disclosed
WO-1998057953-A1 3-BENZYLPIPERIDINE MERCK PATENT GMBH (DE) 1998-12-23 WO disclosed
EP-0071126-B1 PROCESS FOR THE MANUFACTURE OF ALDEHYDES BAYER AG (DE) 1984-09-12 EP disclosed
US-4420435-A Alpha-hydroxy-phosphonic acid esters BAYER AKTIENGESELLSCHAFT (DE) 1983-12-13 US disclosed
EP-0031915-B1 PROCESS FOR THE PRODUCTION OF HALOALKENES BAYER AG (DE) 1983-05-25 EP disclosed
EP-0071126-A1 Process for the manufacture of aldehydes BAYER AG (DE) 1983-02-09 EP disclosed
US-4358409-A Preparation of styryl cyclopropane insecticide intermediates BAYER AKTIENGESELLSCHAFT (DE) 1982-11-09 US disclosed
EP-0019719-B1 PROCESS FOR PREPARING ALKENES, NOVEL INTERMEDIATES FOR THEIR PREPARATION AND PROCESS FOR PREPARING THEM BAYER AG (DE) 1982-07-21 EP disclosed
US-4330482-A Process for the preparation of halogenoalkenes BAYER AKTIENGESELLSCHAFT (DE) 1982-05-18 US disclosed
EP-0031915-A1 Process for the production of haloalkenes BAYER AG (DE) 1981-07-15 EP disclosed
EP-0019719-A1 Process for preparing alkenes, novel intermediates for their preparation and process for preparing them BAYER AG (DE) 1980-12-10 EP disclosed